Navigation Links
Drop in breast cancer incidence linked to hormone use, not mammograms
Date:8/14/2007

A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online August 14 in the Journal of the National Cancer Institute. It is more likely due to the drop in postmenopausal hormone use.

There has been a recent, rapid decline in postmenopausal hormone therapy use since 2002 when the Womens Health Initiative study found that hormone therapy was associated with an increased risk of breast cancer. Recent data has linked a decrease in breast cancer incidence over the last few years to this drop in hormone use, but this explanation remains controversial. Some researchers have said it is unclear whether the drop was related to the decline in hormone therapy use or a decrease in mammography screening over the same period.

Karla Kerlikowske, M.D., of the University of California, San Francisco and colleagues from the Breast Cancer Surveillance Consortium addressed this question by examining breast cancer rates in a population of women collected from seven mammography registries located in the U.S. who had received screening mammograms between 1997 and 2003. They collected data on over 600,000 mammograms performed on women ages 50 to 69. This is the first study to investigate breast cancer incidence and hormone therapy use in a population of women undergoing routine mammograms.

Between 2000 and 2003, use of hormone therapy among the study population declinedby 7 percent a year between 2000 and 2002, then by 34 percent a year between 2002 and 2003. Over the same period, breast cancer incidence rates declined annually by 5 percent. Estrogen-receptor positive breast cancer rates fell by 13 percent each year from 2001 to 2003.

Our results suggest that a decline in postmenopausal hormone therapy use has contributed to the decline in breast cancer incidence in the United States and that the small decline in screening mammography observed in the United States is unlikely to explain the national declines in breast cancer incidence, the authors write.


'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Ductal lavage may detect early breast cancer
4. Breast Feeding prevents obesity later on in life
5. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
6. Breast milk is essential
7. Micro-camera provides new breast imaging technique
8. Breast Cancer Surgery Causes Psychological problems
9. Breast cancer evidence
10. Support therapy helps breast cancer patients
11. Letrozole Beats Tamoxifen in Breast Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology: